Arkolith/Insider Trading/SPRY/Form 4

Shah Pratik

DirectorARS Pharmaceuticals, Inc. (SPRY) · full profile →Form 4 · filed Nov 14, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 12, 2025Gift(G)100K—$04.5M
Nov 12, 2025Gift(G)250K—$04.6M

Transaction Codes

G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001580787-25-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML